$177.30
N/A
À la clôture: Nov 13, 4:00 PM EST
ICU Medical rose 28.0% from $138.53 to $177.30, ahead of the S&P 500's +12.7%. Its worst day was Apr 29 (−4.6%), and its low came Apr 29 at $115.45.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
ICU Medical shares rose 6.0%, while the S&P 500 rose 1.0%.
+6.0% · S&P 500 +1.0%
EPS of $1.91 beat the $1.54 estimate on $540.7M revenue (est. $536.3M); FY EPS guidance of $7.75–$8.45 against the $7.41 consensus.
Story events cover the past 12 months · Times ET
+4.9% · S&P 500 +0.7%
ICU Medical closed at its lowest level of the year, 16.7% below where the year started.
−4.6%, the year's worst day · S&P 500 0.0%
EPS of $1.97 beat the $1.67 estimate on $530.2M revenue (est. $528.9M); FY EPS guidance of $7.75–$8.45 against the $7.74 consensus.
+2.7% · S&P 500 +0.8%
EPS of $2.37 beat the $1.82 estimate on $551.7M revenue (est. $534.0M); FY EPS guidance of $8.60–$9.00 against the $7.83 consensus.
+10.9%, the year's best day, on 931K shares, the year's heaviest volume · S&P 500 +0.6%
ICU Medical closed at its highest level of the year, 35.2% above where the year started.
+1.9% · S&P 500 +0.2%
EPS of $2.44 beat the $2.07 estimate on $560.4M revenue (est. $553.8M); FY EPS guidance of $8.60–$9.00 against the $8.45 consensus.
+2.7% · S&P 500 +0.3%
Where it ended: a close of $177.30 on Nov 12, 2026. Up next: Q4 2026 earnings on Feb 18, 2027 (EPS est. $2.09, revenue est. $560.3M).
Nothing in the past 12 months.
All ICUI dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ICUI and SPY from Benzinga historical bars. Not investment advice.